» Articles » PMID: 15662826

Gamma Knife Surgery for Atypical Meningiomas

Overview
Journal J Neurosurg
Specialty Neurosurgery
Date 2005 Jan 25
PMID 15662826
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Object: Complete resection is the optimal treatment for atypical meningiomas (AMs) but its feasibility depends on the tumor site. The object of this study was to assess the effect of gamma knife surgery (GKS) on AM.

Methods: In 15 patients 21 AMs were treated by GKS. Four patients had residual lesions and 10 patients had recurrent tumors after one or more microsurgical interventions. Three patients were treated twice with GKS because of tumor tissue outside the treatment volume, either at the margin or at a distant location. The median clinical and neuroimaging follow-up period was 35 months (range 21-67 months). Ten tumors shrank 6 to 12 months after GKS, 10 remained stable, and one grew. Between 18 and 36 months after GKS, four patients had a distant recurrence, and two had a margin recurrence. In one of these cases, an additional local recurrence was demonstrated 1 year later, and the patient underwent standard radiotherapy. No patient suffered persistent adverse effects after radiosurgery.

Conclusions: After early tumor shrinkage, high recurrence rates were demonstrated both at the treatment margin and at distant locations in cases treated for AM. There was only one recurrence within the GKS radiation field. For small- and medium-sized AMs GKS may be a safe adjunct to other treatment modalities.

Citing Articles

Radiosurgery in Grade II and III Meningiomas: A Systematic Review and Meta-Analysis.

Jahanbakhshi A, Najafi M, Gomar M, Ciammella P, Ruggieri M, Iotti C J Pers Med. 2024; 14(8).

PMID: 39201994 PMC: 11355310. DOI: 10.3390/jpm14080802.


Frontiers of Cranial Base Surgery: Integrating Technique, Technology, and Teamwork for the Future of Neurosurgery.

Toader C, Eva L, Tataru C, Covache-Busuioc R, Bratu B, Dumitrascu D Brain Sci. 2023; 13(10).

PMID: 37891862 PMC: 10605159. DOI: 10.3390/brainsci13101495.


Stereotactic Therapies for Meningiomas.

Tuleasca C, Ruess D, Ruge M, Regis J Adv Exp Med Biol. 2023; 1416:107-119.

PMID: 37432623 DOI: 10.1007/978-3-031-29750-2_9.


Efficacy of radiotherapy and stereotactic radiosurgery as adjuvant or salvage treatment in atypical and anaplastic (WHO grade II and III) meningiomas: a systematic review and meta-analysis.

Gagliardi F, De Domenico P, Snider S, Pompeo E, Roncelli F, Barzaghi L Neurosurg Rev. 2023; 46(1):71.

PMID: 36928326 DOI: 10.1007/s10143-023-01969-7.


Post Surgical Management of WHO Grade II Meningiomas: Our Experience, the Role of Gamma Knife and a Literature Review.

Migliorati K, Spatola G, Giudice L, de Graaf N, Bassetti C, Giorgi C Life (Basel). 2023; 13(1).

PMID: 36675987 PMC: 9865644. DOI: 10.3390/life13010037.